Redefining Cancer Diagnostics & Personalized Therapeutics
Precision tools for early detection, rare-cell profiling, and therapy design—made for real-world impact.
Oncology-Focused Diagnostics & Therapeutic Blueprinting for Personalized Care
At Prangenix Therapeutics, we are building a next-gen platform for modular diagnostics, rare-cell profiling, and therapeutic blueprinting—designed to bring clarity, control, and customization to cancer and chronic disease care.
Our goal is simple: make high-resolution molecular insight not only possible, but practical—for researchers, clinicians, and biotech innovators.
Our Innovative Therapeutics & Diagnostics Pipeline
At Prangenix, we are building a robust pipeline that integrates multi-omics diagnostics and therapeutics focused on quiescent cancer stem cells (qCSCs). Our programs leverage cutting-edge technologies like liquid biopsy, AI-driven biomarker discovery, single-cell sequencing, and CRISPR-based therapies to accelerate innovation in cancer care.
| Program | Modality | Stage | Next Milestone |
|---|---|---|---|
| HNSCC Dx panel | cfDNA / cfRNA / miRNA liquid biopsy | Assay design complete | 30–60 sample validation |
| Multi-disease Dx panel | Multi-omics + AI biomarker discovery | Preclinical research | Candidate selection |
| HNSCC qCSC therapy | Single-cell seq + CRISPR + AI | Target ID | In vitro validation |
| Multi-disease qCSC therapy | Single-cell seq + CRISPR + AI | Early research | Target prioritization |
Why Choose Prangenix?
Modular by Design
Our diagnostic and therapeutic platforms are built to be flexible. Choose only the targets, genes, or modules that match your specific research or clinical goals—no one-size-fits-all panels.
Built for Precision
Leveraging single-cell sequencing, AI-based target mining, and molecular-level insights, we enable more accurate, context-specific diagnostics and therapy design.
Scalable & Integrable
All our results are delivered via interactive dashboards, compatible with your EMR/LIMS systems, ensuring seamless integration into clinical workflows or research pipelines.
Partner-First Mindset
We believe innovation thrives on collaboration. Our team co-develops solutions with clinicians, hospitals, research institutes, and biotech startups across India and globally.
Join Our Innovation Ecosystem
Academic Collaborators
For co-publications, pilot studies, and translational validation.
Biotech Partners
For co-development of novel diagnostics and therapies.
Clinical Beta Testers
For validating workflows in real-world settings.
Pharma Co-Developers
For therapeutic discovery, target validation, and preclinical studies.
Precision Is Just the Beginning
At Prangenix, we’re not just developing tools—we’re designing a future where diagnosis is faster, therapies are smarter, and every patient journey is guided by molecular clarity. Our modular platforms, rare-cell profiling pipelines, and AI-powered therapeutic engines are built to evolve with science—and with you. Whether you’re a researcher, clinician, or innovator, we invite you to shape the next era of precision care by partnering with us. Because the future of medicine isn’t one-size-fits-all. It’s personal—and it’s powered by Prangenix.